Leaders and researchers from Rice University and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer .
The Cancer Bioengineering Collaborative is a joint initiative between the two institutions created to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Attendees gathered at the TMC 3 Collaborative Building in Helix Park for the kickoff event were welcomed by the leaders of the initiative, Rices Gang Bao and MD Andersons Jeffrey Molldrem , and enjoyed opening remarks by leading officials from the two institutions, who expressed their enthusiasm and support for the joint undertaking.
As both institutions continue to make breakthroughs every day, we hope this collaborative will enable us to tackle the complex challenges of cancer care and treatment more effectively, ultimately improving the lives of patients here in Houston and beyond, said Carin Hagberg, senior vice president and chief academic officer at MD Anderson. Whether our researchers are working on the South Campus or within the hedges of Rice , this collaborative will strengthen each others efforts and push the boundaries of what is possible in cancer.
Additional speakers from MD Anderson included Eyal Gottlieb , vice president for research, and Nobel laureate James Allison , regental professor and chair of immunology and director of the James P. Allison Institute .
